Julio Galindo
University of Alcalá
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Julio Galindo.
Journal of Andrology | 2016
Berniza Calderón; Jesús M. Gómez-Martín; Belén Vega-Piñero; Antonia Martín-Hidalgo; Julio Galindo; Manuel Luque-Ramírez; Héctor F. Escobar-Morreale; José I. Botella-Carretero
To study the prevalence of male obesity‐secondary hypogonadism (MOSH) in patients with moderate to severe obesity, we performed a prospective prevalence study including 100 male patients with moderate to severe obesity at a university tertiary hospital. Total testosterone (TT) and sex hormone‐binding globulin (SHBG) concentrations among others were assayed in all patients. Serum‐free testosterone (FT) concentration was calculated from TT and SHBG levels. Semen analysis was conducted in 31 patients. We found a prevalence of 45% (95% CI: 35–55%) when considering decreased TT and/or FT concentrations. Serum concentrations of TT were correlated negatively with glucose (r = −0.328, p < 0.001) and insulin resistance (r = −0.261, p = 0.011). The same occurred with FT and glucose (r = −0.340, p < 0.001) and insulin resistance (r = −0.246, p = 0.016). Sixty‐two percent (95% CI: 39–85%) of the patients with seminogram also presented abnormal results in semen analysis. The frequencies of low TT or low FT values were similar in patients with abnormal or normal semen analysis (p = 0.646 and p = 0.346, respectively). Ejaculate volume inversely correlated with BMI (ρ = −0.400, p = 0.029) and with excess body weight (ρ = −0.464, p = 0.010). Our data show the prevalence of MOSH in patients with moderate to severe obesity is high. Low circulating testosterone is associated with insulin resistance and low ejaculate volume with higher BMI and excess body weight. Semen analysis must be performed in these patients when considering fertility whether or not presenting low circulating testosterone.
Surgery for Obesity and Related Diseases | 2017
Jesús M. Gómez-Martín; Enrique Aracil; Julio Galindo; Héctor F. Escobar-Morreale; José A. Balsa; José I. Botella-Carretero
BACKGROUND Bariatric surgery may diminish cardiovascular risk (CVR) and its associated mortality. However, studies that compare these effects with different techniques are scarce. OBJECTIVE To evaluate the changes in CVR as estimated by carotid intima-media thickness (IMT) after obesity surgery in women with high CVR as defined by the presence of metabolic syndrome. SETTING Academic hospital. METHODS We studied 40 severely obese women, of whom 20 received laparoscopic Roux en Y gastric bypass (RYGB) and 20 received sleeve gastrectomy (SG). Twenty control women matched for age and cardiovascular risk were also included. Patients and controls were evaluated at baseline and 1 year after surgery or conventional treatment with diet and exercise, respectively. Only 18 of the 20 women in the control group were available for analysis after 1 year. None of the women who had bariatric surgery was lost to follow-up. RESULTS Mean carotid IMT decreased 1 year after surgery irrespective of the surgical technique used, whereas no changes were observed in the control women who had conventional therapy (Wilks´ λ = .802, P = .002 for the interaction, P = .011 for RYGB versus controls, P = .002 for SG versus controls, P = .349 for RYGB versus SG). CONCLUSION Both RYGB and SG decrease CVR as measured by carotid IMT in obese women.
Mini-invasive Surgery | 2018
Pablo Priego; Marta Cuadrado; Francisca García-Moreno; Pedro Carda; Julio Galindo
Aim: Laparoscopic wedge resection is widely accepted as the choice of treatment for gastric submucosal tumors (GST). However, tumors on the posterior wall at the esophagogastric junction (EGJ) are difficult to approach. Laparoscopic transgastric resection (LTR) is a novel technique to remove gastric tumors that are unresectable by endoscopy due to their size and location. The aim of the article is to assess the feasibility and oncological outcomes of this laparoscopic approach for intraluminal GST located in the posterior wall and near the EGJ. Methods: A retrospective analysis of all patients with GST located at the EGJ who underwent LTR at our institution from January 2015 to February 2016 was performed. Results: Of the 4 patients who underwent LTR, 3 were female and 1 was male, with a mean age of 74.5 years. LTR was successfully performed in all the cases. All patients received a complete resection with negative margins. Histopathologic diagnoses were gastrointestinal stromal tumor in 2 cases and leiomyoma in the other 2. Median tumor size was 3.45 cm. The mean operation time was 173 min (range 120-232 min). One patient experienced a postoperative hematemesis, but was treated conservatively. The mean postoperative stay was 8 days (range 4-15 days). Conclusions: LTR is feasible and difficult localizations can be reached with ease. It is an appropriate alternative to laparoscopic wedge resections especially for localizations that cannot be accessed by laparoscopy such as tumors located near the EGJ.
Revista Espanola De Enfermedades Digestivas | 2017
Ana Puerta; Pablo Priego; Julio Galindo
Cytomegalovirus (CMV) colitis is a common entity in immunocompromised patients, being rare among immunocompetent individuals. In addition, its association with ischemic colitis is unusual in both groups of population. Rectal bleeding might occur in both entities and, occasionally, urgent surgical treatment may be required, associating high morbility rates. We report one case of cytomegalovirus colitis associated with severe ischemic colitis in a non- immunocompromised patient with favourable response to conservative management with antiviral therapy.
Obesity Surgery | 2014
Berniza Calderón; Alba Galdón; Alfonso Calañas; Roberto Peromingo; Julio Galindo; Francisca García-Moreno; Gloria Rodriguez-Velasco; Antonia Martín-Hidalgo; Clotilde Vázquez; Héctor F. Escobar-Morreale; José I. Botella-Carretero
Journal of Bone and Mineral Metabolism | 2016
José A. Balsa; Christian Lafuente; Jesús M. Gómez-Martín; Julio Galindo; Roberto Peromingo; Francisca García-Moreno; Gloria Rodriguez-Velasco; Javier Martínez-Botas; Diego Gómez-Coronado; Héctor F. Escobar-Morreale; José I. Botella-Carretero
Revista Espanola De Enfermedades Digestivas | 2016
María de los Ángeles Cornejo; Pablo Priego; Diego Ramos; Magdalena Coll; Araceli Ballestero; Julio Galindo; Francisca García-Moreno; G. Rodriguez; Pedro Carda; Eduardo Lobo
Endocrinología y Nutrición | 2014
Bruno Francisco García Bray; Roberto Peromingo; Julio Galindo; Francisco Arrieta; Juan Sánchez; Clotilde Vázquez; José Ignacio Botella Carretero
Revista Espanola De Enfermedades Digestivas | 2016
Diego Ramos; Pablo Priego; Magdalena Coll; María de los Ángeles Cornejo; Julio Galindo; Gloria Rodriguez-Velasco; Francisca García-Moreno; Pedro Carda; Eduardo Lobo
Obesity Surgery | 2016
José I. Botella-Carretero; Christian Lafuente; Rafael Montes-Nieto; José A. Balsa; Belén Vega-Piñero; Francisca García-Moreno; Roberto Peromingo; Julio Galindo; José L. San-Millán; Héctor F. Escobar-Morreale